Revolution Medicines, Inc. is 11.7x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($30.74 B vs $2.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TARS | RVMD |
|---|---|---|
| Market cap | $2.64 B | $30.74 B |
| US-listed rank | #1904 | #453 |
| Revenue (latest FY) | $451.36M | $0.00 |
| Net income (latest FY) | -$66.00M | -$1.13B |
| Net margin | -14.6% | - |
| SEC filings | 617 | 782 |
Revolution Medicines, Inc. is 11.7x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($30.74 B vs $2.64 B).
In their latest fiscal years, Tarsus Pharmaceuticals, Inc. reported $451.36M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Tarsus Pharmaceuticals, Inc. and Revolution Medicines, Inc., or browse the full rankings.